{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:22:59Z","timestamp":1794248579392,"version":"4.9.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013088","name":"Qinglan Project of Jiangsu Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.116876","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T12:00:47Z","timestamp":1785153647000},"page":"116876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and external validation of a machine learning model for predicting tigecycline-associated drug-induced liver injury"],"prefix":"10.1016","volume":"29","author":[{"given":"Yujing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2992-9783","authenticated-orcid":false,"given":"Wenkui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116876_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(24)02081-6","article-title":"Multidrug-resistant Gram-negative bacterial infections","volume":"405","author":"Macesic","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.116876_bib2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1473-3099(11)70177-3","article-title":"Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis","volume":"11","author":"Tasina","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.116876_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00497","article-title":"Prescription patterns for tigecycline in severely ill patients for non-FDA approved indications in a developing country: a compromised outcome","volume":"8","author":"Moghnieh","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2026.116876_bib4","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1517\/17425255.2011.623126","article-title":"Pharmacokinetic and pharmacodynamic evaluation of tigecycline","volume":"7","author":"Giamarellou","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.isci.2026.116876_bib5","first-page":"2146","article-title":"Risk of liver function abnormalities with tigecycline: a retrospective observational study","volume":"44","author":"Zuo","year":"2024","journal-title":"Chin. J. Hosp. Pharm."},{"key":"10.1016\/j.isci.2026.116876_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamainternmed.2015.6058","article-title":"Association of off-label drug use and adverse drug events in an adult population","volume":"176","author":"Eguale","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.isci.2026.116876_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.761167","article-title":"Real-world data of tigecycline-associated drug-induced liver injury among patients in China: a 3-year retrospective study as assessed by the updated Roussel Uclaf Causality Assessment Method","volume":"12","author":"Shi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.116876_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijid.2022.04.024","article-title":"Prevalence and risk factors of tigecycline-induced liver injury: a multicenter retrospective study","volume":"120","author":"Yu","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116876_bib9","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/jcph.2099","article-title":"Risk factors for tigecycline-associated hepatotoxicity in patients in the intensive care units of 2 tertiary hospitals: a retrospective study","volume":"62","author":"Jiang","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.isci.2026.116876_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1512091","article-title":"Prediction and analysis of toxic and side effects of tigecycline based on deep learning","volume":"15","author":"Xiong","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2026.116876_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamainternmed.2024.1836","article-title":"Severe acute liver injury after hepatotoxic medication initiation in real-world data","volume":"184","author":"Torgersen","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.isci.2026.116876_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2025.154359","article-title":"Advances in antituberculosis drug-induced liver injury: molecular mechanisms, genetic insights, and emerging animal-free prediction models","volume":"520","author":"Yang","year":"2026","journal-title":"Toxicology"},{"key":"10.1016\/j.isci.2026.116876_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tig.2020.03.005","article-title":"Opening the black box: interpretable machine learning for geneticists","volume":"36","author":"Azodi","year":"2020","journal-title":"Trends Genet."},{"key":"10.1016\/j.isci.2026.116876_bib14","article-title":"The application of explainable artificial intelligence in the prediction, diagnoses, treatment, and management of chronic diseases: a systematic review","volume":"11","author":"Hoghooghi Esfahani","year":"2025","journal-title":"Digit. Health"},{"key":"10.1016\/j.isci.2026.116876_bib15","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","author":"Andrade","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.isci.2026.116876_bib16","article-title":"A nomogram for predicting the risk of tigecycline-associated drug-induced liver injury in a Chinese population","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.116876_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1697929","article-title":"Predicting tigecycline-related adverse events in infected patients: a machine learning approach with clinical interpretability","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.116876_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.25007\/ajnu.v12n2a1612","article-title":"Exploring the power of eXtreme Gradient Boosting algorithm in machine learning: a review","volume":"12","author":"Ali","year":"2023","journal-title":"Acad. J. Nawroz Univ."},{"key":"10.1016\/j.isci.2026.116876_bib19","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s10462-020-09896-5","article-title":"A comparative analysis of gradient boosting algorithms","volume":"54","author":"Bent\u00e9jac","year":"2021","journal-title":"Artif. Intell. Rev."},{"key":"10.1016\/j.isci.2026.116876_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41512-025-00214-7","article-title":"The F score ranks diagnostic tests and prediction models inconsistently with their clinical utility","volume":"9","author":"Assel","year":"2025","journal-title":"Diagn. Progn. Res."},{"key":"10.1016\/j.isci.2026.116876_bib21","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1186\/s12967-023-04615-4","article-title":"Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells","volume":"21","author":"Koch","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.116876_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/FTD.0000000000001115","article-title":"Pharmacokinetic\/pharmacodynamic target attainment of tigecycline in patients with hepatic impairment in a real-world setting","volume":"45","author":"Yang","year":"2023","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.isci.2026.116876_bib23","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1111\/jcmm.14070","article-title":"New therapeutic strategy of hinokitiol in haemorrhagic shock-induced liver injury","volume":"23","author":"Lu","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.isci.2026.116876_bib24","doi-asserted-by":"crossref","first-page":"S333","DOI":"10.1086\/431674","article-title":"The pharmacokinetic and pharmacodynamic profile of tigecycline","volume":"41","author":"Meagher","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2026.116876_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/ijms17010014","article-title":"RUCAM in drug and herb induced liver injury: the update","volume":"17","author":"Danan","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116876_bib26","article-title":"Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases","volume":"98","author":"Gong","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.isci.2026.116876_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08815-7","article-title":"Clinical efficacy and safety of tigecycline based on therapeutic drug monitoring for carbapenem-resistant Gram-negative bacterium pneumonia in intensive care units","volume":"23","author":"Bai","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.isci.2026.116876_bib28","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1080\/10618600.2022.2035739","article-title":"Variable selection with multiply-imputed datasets: choosing between stacked and grouped methods","volume":"31","author":"Du","year":"2022","journal-title":"J. Comput. Graph Stat."},{"key":"10.1016\/j.isci.2026.116876_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1467-9868.2010.00740.x","article-title":"Stability selection","volume":"72","author":"Meinshausen","year":"2010","journal-title":"J. R. Stat. Soc. Series B Stat. Methodol"},{"key":"10.1016\/j.isci.2026.116876_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/CLEP.S129785","article-title":"Missing data and multiple imputation in clinical epidemiological research","volume":"9","author":"Pedersen","year":"2017","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.isci.2026.116876_bib31","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226022546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226022546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:57:14Z","timestamp":1794247034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226022546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226022546"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116876","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and external validation of a machine learning model for predicting tigecycline-associated drug-induced liver injury","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116876"}}